Abiomed (NASDAQ: ABMD) announces the first two patients in the world have been treated with the Abiomed Breethe OXY-1 System, a compact cardiopulmonary bypass system.
Minnetronix Medical, which partners with companies throughout the world to design, develop and manufacture medical device technology, today announced that it has been awarded a National Institutes of Health (NIH) granti for continued study of its proprietary Neurapheresis™ Cerebrospinal Fluid Treatment Platform.
Masimo (NASDAQ: MASI) today announced the findings of an abstract recently presented at ANESTHESIOLOGY® 2020, the Annual Meeting of the American Society of Anesthesiologists (ASA).
Beckman Coulter, a clinical diagnostics leader, today announced its Access SARS-CoV-2 Immunoglobulin M (IgM) assay has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).
Kardium Inc. announced the first commercial procedures with the Globe Mapping and Ablation System.
Ambu Inc., the world leader in single-use endoscopes, announced today that it has been awarded a contract with UroGPO, the largest Group Purchasing Organization for urology private practice clinics in the U.S.
Minnetronix Medical has been announced that it has received FDA clearance for its first platform product: the MindsEye™ Expandable Port for neurosurgical procedures.
Masimo today announced that PVi® has received FDA clearance as a continuous, noninvasive, dynamic indicator of fluid responsiveness in select populations of mechanically ventilated adult patients.
Confluent Medical Technologies (“Confluent”), a global leader in contract manufacturing of specialized medical devices, today announced the opening of its new Complex Catheter Design and Development Center in Austin, Texas.
Joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is pleased to announce that Intracs®em, its electromagnetic navigation tracking and control system, has been approved by the FDA.